HF 2476 Minnesota House · 2025-2026 Regular Session

Over-the-counter allergy medicine sale restrictions modified.

HF 2476 modifies Minnesota's restrictions on over-the-counter sales of products containing ephedrine or pseudoephedrine (commonly found in some allergy medications and cold remedies, but primarily regulated due to their use in methamphetamine production). The bill limits single sales to no more than 6 grams of these substances (by weight), requires sales to occur behind a counter with a licensed pharmacist, mandates ID checks showing date of birth, and requires written records of each sale to be kept for three years. It also prohibits sales to anyone under 18 and caps total purchases at 7.2 grams within 30 days. These changes directly affect pharmacies selling such products and customers purchasing them.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 17, 2025 Last action Mar 17, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Mar 17, 2025
Introduced
Introduction and first reading, referred to Health Finance and Policy
lower
1 primary · 1 co-sponsor

Sponsors